GILD GILEAD SCIENCES INC
2026Q1 · CUSIP 375558103 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
2,307
Δ holders QoQ
+95
Breadth percentile
Top 2%
Whale holders
349
Δ whales
+6
Inst. holding value
$142.6B
New positions
247
Closed positions
152
Price momentum (1Q)
-16.0%
Put / Call
39/41
Breadth history (34 quarters)
Past Lit Events & Aftermath 10 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 2% | — | — |
| 2025Q4 | Top 1% | -16.0% | — |
| 2025Q1 | Top 0% | +11.9% | +18.5% |
| 2024Q4 | Top 2% | +1.6% | +13.7% |
| 2024Q3 | Top 9% | +25.3% | +22.5% |
| 2023Q4 | Top 4% | -4.4% | +6.4% |
| 2022Q4 | Top 1% | -5.3% | -7.3% |
| 2021Q4 | Top 3% | +3.4% | +8.0% |
| 2020Q1 | Top 1% | -6.7% | -17.4% |
| 2019Q4 | Top 4% | +12.6% | +5.1% |
Options Sentiment
Put holders
39
QoQ: +1
Call holders
41
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
18.1
EPS (TTM)
$7.35
EPS YoY
+54.4%
Revenue (TTM)
$29.7B
Revenue YoY
+3.5%
Net margin
31.0%
ROE
39.2%
Debt ratio
58.2%
FCF (TTM)
$10.2B
Dividend (TTM)
$3.19
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.